Niaid SPF macaque breeding colonies
Ended Awarded Last action
- Contract number
- 75N93025F00001
- Awardee
-
Alpha Genesis Inc. UEI H7E8FHEF7ND5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,408,640
Award facts
- Contract value 100% obligated
- $8,408,640.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Yemassee, SC, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $8.4 million to Alpha Genesis Inc. for the maintenance and management of specific pathogen-free (SPF) macaque breeding colonies. Scheduled for completion by September 29, 2026, this cost-plus-fixed-fee contract represents work performed at Alpha Genesis's facility in Yemassee, South Carolina. The award does not utilize a set-aside designation, indicating Alpha Genesis competed in the open market for this opportunity. This delivery order falls under a larger NIAID Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle valued at $48 million and extending through September 29, 2031, which provides a comprehensive framework for nonhuman primate acquisition, breeding, and support services.
Alpha Genesis Inc., a South Carolina-based for-profit corporation, is a specialized supplier of nonhuman primates and related biomedical research services to federal agencies. The company maintains extensive breeding colonies and provides critical support services including animal care, testing, transportation, and colony maintenance to multiple National Institutes of Health institutes. Through its work with NIAID and other federal research institutions, Alpha Genesis plays a key role in supporting infectious disease research, vaccine development, immunology studies, and other essential biomedical research programs that require carefully managed nonhuman primate populations.
Quick answers
Who was awarded contract 75N93025F00001?
75N93025F00001 was awarded to Alpha Genesis Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.
How much is contract 75N93025F00001 worth?
The government has obligated $8,408,640 on 75N93025F00001.
Is contract 75N93025F00001 an order under another contract?
Yes. 75N93025F00001 is a delivery order under 75N93024D00044, an indefinite delivery contract.
Was contract 75N93025F00001 competed?
The extent of competition for 75N93025F00001 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award